Table of Content

1 Market Overview of Haemophilia Drug
1.1 Haemophilia Drug Market Overview
1.1.1 Haemophilia Drug Product Scope
1.1.2 Haemophilia Drug Market Status and Outlook
1.2 Global Haemophilia Drug Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Haemophilia Drug Market Size by Region (2024-2034)
1.4 Global Haemophilia Drug Historic Market Size by Region (2024-2024)
1.5 Global Haemophilia Drug Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Haemophilia Drug Market Size (2024-2034)
1.6.1 North America Haemophilia Drug Market Size (2024-2034)
1.6.2 Europe Haemophilia Drug Market Size (2024-2034)
1.6.3 Asia-Pacific Haemophilia Drug Market Size (2024-2034)
1.6.4 Latin America Haemophilia Drug Market Size (2024-2034)
1.6.5 Middle East & Africa Haemophilia Drug Market Size (2024-2034)
2 Haemophilia Drug Market by Type
2.1 Introduction
2.1.1 Blood-derived Coagulation Factor
2.1.2 Recombinant Coagulation Factor
2.2 Global Haemophilia Drug Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Haemophilia Drug Historic Market Size by Type (2024-2024)
2.2.2 Global Haemophilia Drug Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Haemophilia Drug Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Haemophilia Drug Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Haemophilia Drug Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Haemophilia Drug Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Haemophilia Drug Revenue Breakdown by Type (2024-2034)
3 Haemophilia Drug Market Overview by Application
3.1 Introduction
3.1.1 Haemophilia A
3.1.2 Haemophilia B
3.1.3 Others
3.2 Global Haemophilia Drug Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Haemophilia Drug Historic Market Size by Application (2024-2024)
3.2.2 Global Haemophilia Drug Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Haemophilia Drug Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Haemophilia Drug Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Haemophilia Drug Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Haemophilia Drug Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Haemophilia Drug Revenue Breakdown by Application (2024-2034)
4 Haemophilia Drug Competition Analysis by Players
4.1 Global Haemophilia Drug Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Haemophilia Drug as of 2022)
4.3 Date of Key Players Enter into Haemophilia Drug Market
4.4 Global Top Players Haemophilia Drug Headquarters and Area Served
4.5 Key Players Haemophilia Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Haemophilia Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Shire (Baxter)
5.1.1 Shire (Baxter) Profile
5.1.2 Shire (Baxter) Main Business
5.1.3 Shire (Baxter) Haemophilia Drug Products, Services and Solutions
5.1.4 Shire (Baxter) Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.1.5 Shire (Baxter) Recent Developments
5.2 CSL
5.2.1 CSL Profile
5.2.2 CSL Main Business
5.2.3 CSL Haemophilia Drug Products, Services and Solutions
5.2.4 CSL Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.2.5 CSL Recent Developments
5.3 Grifols
5.3.1 Grifols Profile
5.3.2 Grifols Main Business
5.3.3 Grifols Haemophilia Drug Products, Services and Solutions
5.3.4 Grifols Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.3.5 Biogen Recent Developments
5.4 Biogen
5.4.1 Biogen Profile
5.4.2 Biogen Main Business
5.4.3 Biogen Haemophilia Drug Products, Services and Solutions
5.4.4 Biogen Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.4.5 Biogen Recent Developments
5.5 Octapharma
5.5.1 Octapharma Profile
5.5.2 Octapharma Main Business
5.5.3 Octapharma Haemophilia Drug Products, Services and Solutions
5.5.4 Octapharma Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.5.5 Octapharma Recent Developments
5.6 Kedrion
5.6.1 Kedrion Profile
5.6.2 Kedrion Main Business
5.6.3 Kedrion Haemophilia Drug Products, Services and Solutions
5.6.4 Kedrion Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.6.5 Kedrion Recent Developments
5.7 BPL
5.7.1 BPL Profile
5.7.2 BPL Main Business
5.7.3 BPL Haemophilia Drug Products, Services and Solutions
5.7.4 BPL Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.7.5 BPL Recent Developments
5.8 Bayer
5.8.1 Bayer Profile
5.8.2 Bayer Main Business
5.8.3 Bayer Haemophilia Drug Products, Services and Solutions
5.8.4 Bayer Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.8.5 Bayer Recent Developments
5.9 Novo Nordisk
5.9.1 Novo Nordisk Profile
5.9.2 Novo Nordisk Main Business
5.9.3 Novo Nordisk Haemophilia Drug Products, Services and Solutions
5.9.4 Novo Nordisk Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.9.5 Novo Nordisk Recent Developments
5.10 Pfizer
5.10.1 Pfizer Profile
5.10.2 Pfizer Main Business
5.10.3 Pfizer Haemophilia Drug Products, Services and Solutions
5.10.4 Pfizer Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.10.5 Pfizer Recent Developments
5.11 Roche
5.11.1 Roche Profile
5.11.2 Roche Main Business
5.11.3 Roche Haemophilia Drug Products, Services and Solutions
5.11.4 Roche Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.11.5 Roche Recent Developments
5.12 Baxter
5.12.1 Baxter Profile
5.12.2 Baxter Main Business
5.12.3 Baxter Haemophilia Drug Products, Services and Solutions
5.12.4 Baxter Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.12.5 Baxter Recent Developments
5.13 Sinopharm
5.13.1 Sinopharm Profile
5.13.2 Sinopharm Main Business
5.13.3 Sinopharm Haemophilia Drug Products, Services and Solutions
5.13.4 Sinopharm Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.13.5 Sinopharm Recent Developments
5.14 Shanghai Raas Blood Products
5.14.1 Shanghai Raas Blood Products Profile
5.14.2 Shanghai Raas Blood Products Main Business
5.14.3 Shanghai Raas Blood Products Haemophilia Drug Products, Services and Solutions
5.14.4 Shanghai Raas Blood Products Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.14.5 Shanghai Raas Blood Products Recent Developments
5.15 China Biologic Products
5.15.1 China Biologic Products Profile
5.15.2 China Biologic Products Main Business
5.15.3 China Biologic Products Haemophilia Drug Products, Services and Solutions
5.15.4 China Biologic Products Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.15.5 China Biologic Products Recent Developments
5.16 Hualan Bio
5.16.1 Hualan Bio Profile
5.16.2 Hualan Bio Main Business
5.16.3 Hualan Bio Haemophilia Drug Products, Services and Solutions
5.16.4 Hualan Bio Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.16.5 Hualan Bio Recent Developments
5.17 CGE Healthcare
5.17.1 CGE Healthcare Profile
5.17.2 CGE Healthcare Main Business
5.17.3 CGE Healthcare Haemophilia Drug Products, Services and Solutions
5.17.4 CGE Healthcare Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.17.5 CGE Healthcare Recent Developments
5.18 Sinocelltech Group
5.18.1 Sinocelltech Group Profile
5.18.2 Sinocelltech Group Main Business
5.18.3 Sinocelltech Group Haemophilia Drug Products, Services and Solutions
5.18.4 Sinocelltech Group Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.18.5 Sinocelltech Group Recent Developments
5.19 Shanxi Kangbao Biological
5.19.1 Shanxi Kangbao Biological Profile
5.19.2 Shanxi Kangbao Biological Main Business
5.19.3 Shanxi Kangbao Biological Haemophilia Drug Products, Services and Solutions
5.19.4 Shanxi Kangbao Biological Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.19.5 Shanxi Kangbao Biological Recent Developments
5.20 CTTQ
5.20.1 CTTQ Profile
5.20.2 CTTQ Main Business
5.20.3 CTTQ Haemophilia Drug Products, Services and Solutions
5.20.4 CTTQ Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.20.5 CTTQ Recent Developments
5.21 GC Biopharma
5.21.1 GC Biopharma Profile
5.21.2 GC Biopharma Main Business
5.21.3 GC Biopharma Haemophilia Drug Products, Services and Solutions
5.21.4 GC Biopharma Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.21.5 GC Biopharma Recent Developments
5.22 Belief BioMed
5.22.1 Belief BioMed Profile
5.22.2 Belief BioMed Main Business
5.22.3 Belief BioMed Haemophilia Drug Products, Services and Solutions
5.22.4 Belief BioMed Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.22.5 Belief BioMed Recent Developments
5.23 AryoGen Pharmed
5.23.1 AryoGen Pharmed Profile
5.23.2 AryoGen Pharmed Main Business
5.23.3 AryoGen Pharmed Haemophilia Drug Products, Services and Solutions
5.23.4 AryoGen Pharmed Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.23.5 AryoGen Pharmed Recent Developments
5.24 GENERIUM
5.24.1 GENERIUM Profile
5.24.2 GENERIUM Main Business
5.24.3 GENERIUM Haemophilia Drug Products, Services and Solutions
5.24.4 GENERIUM Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.24.5 GENERIUM Recent Developments
5.25 LFB SA
5.25.1 LFB SA Profile
5.25.2 LFB SA Main Business
5.25.3 LFB SA Haemophilia Drug Products, Services and Solutions
5.25.4 LFB SA Haemophilia Drug Revenue (US$ Million) & (2024-2024)
5.25.5 LFB SA Recent Developments
6 North America
6.1 North America Haemophilia Drug Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Haemophilia Drug Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Haemophilia Drug Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Haemophilia Drug Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Haemophilia Drug Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Haemophilia Drug Market Dynamics
11.1 Haemophilia Drug Industry Trends
11.2 Haemophilia Drug Market Drivers
11.3 Haemophilia Drug Market Challenges
11.4 Haemophilia Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Haemophilia Drug Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Haemophilia Drug Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Haemophilia Drug Market Size Share by Region (2024-2024)
Table 4. Global Haemophilia Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Haemophilia Drug Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Haemophilia Drug Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Haemophilia Drug Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Haemophilia Drug Revenue Market Share by Type (2024-2024)
Table 9. Global Haemophilia Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Haemophilia Drug Revenue Market Share by Type (2024-2034)
Table 11. North America Haemophilia Drug Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Haemophilia Drug Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Haemophilia Drug Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Haemophilia Drug Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Haemophilia Drug Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Haemophilia Drug Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Haemophilia Drug Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Haemophilia Drug Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Haemophilia Drug Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Haemophilia Drug Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Haemophilia Drug Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Haemophilia Drug Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Haemophilia Drug Revenue Market Share by Application (2024-2024)
Table 24. Global Haemophilia Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Haemophilia Drug Revenue Market Share by Application (2024-2034)
Table 26. North America Haemophilia Drug Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Haemophilia Drug Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Haemophilia Drug Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Haemophilia Drug Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Haemophilia Drug Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Haemophilia Drug Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Haemophilia Drug Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Haemophilia Drug Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Haemophilia Drug Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Haemophilia Drug Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Haemophilia Drug Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Haemophilia Drug Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Haemophilia Drug as of 2022)
Table 39. Date of Key Players Enter into Haemophilia Drug Market
Table 40. Global Haemophilia Drug Key Players Headquarters and Area Served
Table 41. Haemophilia Drug Product Solution and Service
Table 42. Global Haemophilia Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Shire (Baxter) Basic Information List
Table 45. Shire (Baxter) Description and Business Overview
Table 46. Shire (Baxter) Haemophilia Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Haemophilia Drug Business of Shire (Baxter) (2024-2024)
Table 48. Shire (Baxter) Recent Developments
Table 49. CSL Basic Information List
Table 50. CSL Description and Business Overview
Table 51. CSL Haemophilia Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Haemophilia Drug Business of CSL (2024-2024)
Table 53. CSL Recent Developments
Table 54. Grifols Basic Information List
Table 55. Grifols Description and Business Overview
Table 56. Grifols Haemophilia Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Haemophilia Drug Business of Grifols (2024-2024)
Table 58. Grifols Recent Developments
Table 59. Biogen Basic Information List
Table 60. Biogen Description and Business Overview
Table 61. Biogen Haemophilia Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Haemophilia Drug Business of Biogen (2024-2024)
Table 63. Biogen Recent Developments
Table 64. Octapharma Basic Information List
Table 65. Octapharma Description and Business Overview
Table 66. Octapharma Haemophilia Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Haemophilia Drug Business of Octapharma (2024-2024)
Table 68. Octapharma Recent Developments
Table 69. Kedrion Basic Information List
Table 70. Kedrion Description and Business Overview
Table 71. Kedrion Haemophilia Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Haemophilia Drug Business of Kedrion (2024-2024)
Table 73. Kedrion Recent Developments
Table 74. BPL Basic Information List
Table 75. BPL Description and Business Overview
Table 76. BPL Haemophilia Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in Haemophilia Drug Business of BPL (2024-2024)
Table 78. BPL Recent Developments
Table 79. Bayer Basic Information List
Table 80. Bayer Description and Business Overview
Table 81. Bayer Haemophilia Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in Haemophilia Drug Business of Bayer (2024-2024)
Table 83. Bayer Recent Developments
Table 84. Novo Nordisk Basic Information List
Table 85. Novo Nordisk Description and Business Overview
Table 86. Novo Nordisk Haemophilia Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in Haemophilia Drug Business of Novo Nordisk (2024-2024)
Table 88. Novo Nordisk Recent Developments
Table 89. Pfizer Basic Information List
Table 90. Pfizer Description and Business Overview
Table 91. Pfizer Haemophilia Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in Haemophilia Drug Business of Pfizer (2024-2024)
Table 93. Pfizer Recent Developments
Table 94. Roche Basic Information List
Table 95. Roche Description and Business Overview
Table 96. Roche Haemophilia Drug Products, Services and Solutions
Table 97. Revenue (US$ Million) in Haemophilia Drug Business of Roche (2024-2024)
Table 98. Roche Recent Developments
Table 99. Baxter Basic Information List
Table 100. Baxter Description and Business Overview
Table 101. Baxter Haemophilia Drug Products, Services and Solutions
Table 102. Revenue (US$ Million) in Haemophilia Drug Business of Baxter (2024-2024)
Table 103. Baxter Recent Developments
Table 104. Sinopharm Basic Information List
Table 105. Sinopharm Description and Business Overview
Table 106. Sinopharm Haemophilia Drug Products, Services and Solutions
Table 107. Revenue (US$ Million) in Haemophilia Drug Business of Sinopharm (2024-2024)
Table 108. Sinopharm Recent Developments
Table 109. Shanghai Raas Blood Products Basic Information List
Table 110. Shanghai Raas Blood Products Description and Business Overview
Table 111. Shanghai Raas Blood Products Haemophilia Drug Products, Services and Solutions
Table 112. Revenue (US$ Million) in Haemophilia Drug Business of Shanghai Raas Blood Products (2024-2024)
Table 113. Shanghai Raas Blood Products Recent Developments
Table 114. China Biologic Products Basic Information List
Table 115. China Biologic Products Description and Business Overview
Table 116. China Biologic Products Haemophilia Drug Products, Services and Solutions
Table 117. Revenue (US$ Million) in Haemophilia Drug Business of China Biologic Products (2024-2024)
Table 118. China Biologic Products Recent Developments
Table 119. Hualan Bio Basic Information List
Table 120. Hualan Bio Description and Business Overview
Table 121. Hualan Bio Haemophilia Drug Products, Services and Solutions
Table 122. Revenue (US$ Million) in Haemophilia Drug Business of Hualan Bio (2024-2024)
Table 123. Hualan Bio Recent Developments
Table 124. CGE Healthcare Basic Information List
Table 125. CGE Healthcare Description and Business Overview
Table 126. CGE Healthcare Haemophilia Drug Products, Services and Solutions
Table 127. Revenue (US$ Million) in Haemophilia Drug Business of CGE Healthcare (2024-2024)
Table 128. CGE Healthcare Recent Developments
Table 129. Sinocelltech Group Basic Information List
Table 130. Sinocelltech Group Description and Business Overview
Table 131. Sinocelltech Group Haemophilia Drug Products, Services and Solutions
Table 132. Revenue (US$ Million) in Haemophilia Drug Business of Sinocelltech Group (2024-2024)
Table 133. Sinocelltech Group Recent Developments
Table 134. Shanxi Kangbao Biological Basic Information List
Table 135. Shanxi Kangbao Biological Description and Business Overview
Table 136. Shanxi Kangbao Biological Haemophilia Drug Products, Services and Solutions
Table 137. Revenue (US$ Million) in Haemophilia Drug Business of Shanxi Kangbao Biological (2024-2024)
Table 138. Shanxi Kangbao Biological Recent Developments
Table 139. CTTQ Basic Information List
Table 140. CTTQ Description and Business Overview
Table 141. CTTQ Haemophilia Drug Products, Services and Solutions
Table 142. Revenue (US$ Million) in Haemophilia Drug Business of CTTQ (2024-2024)
Table 143. CTTQ Recent Developments
Table 144. GC Biopharma Basic Information List
Table 145. GC Biopharma Description and Business Overview
Table 146. GC Biopharma Haemophilia Drug Products, Services and Solutions
Table 147. Revenue (US$ Million) in Haemophilia Drug Business of GC Biopharma (2024-2024)
Table 148. GC Biopharma Recent Developments
Table 149. Belief BioMed Basic Information List
Table 150. Belief BioMed Description and Business Overview
Table 151. Belief BioMed Haemophilia Drug Products, Services and Solutions
Table 152. Revenue (US$ Million) in Haemophilia Drug Business of Belief BioMed (2024-2024)
Table 153. Belief BioMed Recent Developments
Table 154. AryoGen Pharmed Basic Information List
Table 155. AryoGen Pharmed Description and Business Overview
Table 156. AryoGen Pharmed Haemophilia Drug Products, Services and Solutions
Table 157. Revenue (US$ Million) in Haemophilia Drug Business of AryoGen Pharmed (2024-2024)
Table 158. AryoGen Pharmed Recent Developments
Table 159. GENERIUM Basic Information List
Table 160. GENERIUM Description and Business Overview
Table 161. GENERIUM Haemophilia Drug Products, Services and Solutions
Table 162. Revenue (US$ Million) in Haemophilia Drug Business of GENERIUM (2024-2024)
Table 163. GENERIUM Recent Developments
Table 164. LFB SA Basic Information List
Table 165. LFB SA Description and Business Overview
Table 166. LFB SA Haemophilia Drug Products, Services and Solutions
Table 167. Revenue (US$ Million) in Haemophilia Drug Business of LFB SA (2024-2024)
Table 168. LFB SA Recent Developments
Table 169. North America Haemophilia Drug Market Size by Country (2024-2024) & (US$ Million)
Table 170. North America Haemophilia Drug Market Size by Country (2024-2034) & (US$ Million)
Table 171. Europe Haemophilia Drug Market Size by Country (2024-2024) & (US$ Million)
Table 172. Europe Haemophilia Drug Market Size by Country (2024-2034) & (US$ Million)
Table 173. Asia-Pacific Haemophilia Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 174. Asia-Pacific Haemophilia Drug Market Size by Region (2024-2024) & (US$ Million)
Table 175. Asia-Pacific Haemophilia Drug Market Size by Region (2024-2034) & (US$ Million)
Table 176. Asia-Pacific Haemophilia Drug Market Share by Region (2024-2024)
Table 177. Asia-Pacific Haemophilia Drug Market Share by Region (2024-2034)
Table 178. Latin America Haemophilia Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 179. Latin America Haemophilia Drug Market Size by Country (2024-2024) & (US$ Million)
Table 180. Latin America Haemophilia Drug Market Size by Country (2024-2034) & (US$ Million)
Table 181. Middle East & Africa Haemophilia Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 182. Middle East & Africa Haemophilia Drug Market Size by Country (2024-2024) & (US$ Million)
Table 183. Middle East & Africa Haemophilia Drug Market Size by Country (2024-2034) & (US$ Million)
Table 184. Haemophilia Drug Market Trends
Table 185. Haemophilia Drug Market Drivers
Table 186. Haemophilia Drug Market Challenges
Table 187. Haemophilia Drug Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Haemophilia Drug Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Haemophilia Drug Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Haemophilia Drug Market Share by Regions: 2022 VS 2034
Figure 4. Global Haemophilia Drug Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Haemophilia Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Haemophilia Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Haemophilia Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Haemophilia Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Haemophilia Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Blood-derived Coagulation Factor
Figure 11. Global Blood-derived Coagulation Factor Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Recombinant Coagulation Factor
Figure 13. Global Recombinant Coagulation Factor Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Global Haemophilia Drug Market Size Share by Type: 2022 & 2034
Figure 15. North America Haemophilia Drug Revenue Market Share by Type (2024-2034)
Figure 16. Europe Haemophilia Drug Revenue Market Share by Type (2024-2034)
Figure 17. Asia-Pacific Haemophilia Drug Revenue Market Share by Type (2024-2034)
Figure 18. Latin America Haemophilia Drug Revenue Market Share by Type (2024-2034)
Figure 19. Middle East and Africa Haemophilia Drug Revenue Market Share by Type (2024-2034)
Figure 20. Haemophilia A Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 21. Haemophilia B Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 22. Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Global Haemophilia Drug Market Size Share by Application: 2022 & 2034
Figure 24. North America Haemophilia Drug Revenue Market Share by Application (2024-2034)
Figure 25. Europe Haemophilia Drug Revenue Market Share by Application (2024-2034)
Figure 26. Asia-Pacific Haemophilia Drug Revenue Market Share by Application (2024-2034)
Figure 27. Latin America Haemophilia Drug Revenue Market Share by Application (2024-2034)
Figure 28. Middle East and Africa Haemophilia Drug Revenue Market Share by Application (2024-2034)
Figure 29. Haemophilia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 30. Global Top 5 and Top 10 Players Haemophilia Drug Market Share in 2022
Figure 31. North America Haemophilia Drug Market Share by Country (2024-2034)
Figure 32. United States Haemophilia Drug Market Size (2024-2034) & (US$ Million)
Figure 33. Canada Haemophilia Drug Market Size (2024-2034) & (US$ Million)
Figure 34. Germany Haemophilia Drug Market Size (2024-2034) & (US$ Million)
Figure 35. France Haemophilia Drug Market Size (2024-2034) & (US$ Million)
Figure 36. U.K. Haemophilia Drug Market Size (2024-2034) & (US$ Million)
Figure 37. Italy Haemophilia Drug Market Size (2024-2034) & (US$ Million)
Figure 38. Russia Haemophilia Drug Market Size (2024-2034) & (US$ Million)
Figure 39. Nordic Countries Haemophilia Drug Market Size (2024-2034) & (US$ Million)
Figure 40. Asia-Pacific Haemophilia Drug Market Share by Region (2024-2034)
Figure 41. China Haemophilia Drug Market Size (2024-2034) & (US$ Million)
Figure 42. Japan Haemophilia Drug Market Size (2024-2034) & (US$ Million)
Figure 43. South Korea Haemophilia Drug Market Size (2024-2034) & (US$ Million)
Figure 44. Southeast Asia Haemophilia Drug Market Size (2024-2034) & (US$ Million)
Figure 45. India Haemophilia Drug Market Size (2024-2034) & (US$ Million)
Figure 46. Australia Haemophilia Drug Market Size (2024-2034) & (US$ Million)
Figure 47. Latin America Haemophilia Drug Market Share by Country (2024-2034)
Figure 48. Mexico Haemophilia Drug Market Size (2024-2034) & (US$ Million)
Figure 49. Brazil Haemophilia Drug Market Size (2024-2034) & (US$ Million)
Figure 50. Middle East & Africa Haemophilia Drug Market Share by Country (2024-2034)
Figure 51. Turkey Haemophilia Drug Market Size (2024-2034) & (US$ Million)
Figure 52. Saudi Arabia Haemophilia Drug Market Size (2024-2034) & (US$ Million)
Figure 53. UAE Haemophilia Drug Market Size (2024-2034) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report